Eastern Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Eastern Bank’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-791	Closed	-$11K	–	1041
2026 Q1	$11K	Hold	791	–	–	﹤0.01%	831
2025 Q4	$12.8K	Buy	+791	New	+$12.9K	﹤0.01%	828

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eastern Bank's ADPT Position: Q2 2026 in Review

Eastern Bank sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 791 shares — an estimated $11K sold.

Eastern Bank first reported a position in ADPT in Q4 2025 and held it in 2 quarters. The position peaked at $12.8K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Eastern Bank reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
Eastern Bank sold 791 Adaptive Biotechnologies shares in Q2 2026, an estimated $11K.
Eastern Bank first reported a position in Adaptive Biotechnologies in Q4 2025 and held it in 2 quarters.
Eastern Bank's Adaptive Biotechnologies position peaked at $12.8K in Q4 2025.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.